Allogene Therapeutics, Inc. (NASDAQ:ALLO) Cap table
Cap table
Built by 6ix from Allogene Therapeutics, Inc.’s releases · as of Nov 3, 2026
- Common shares
- 346,467,307
- Fully diluted
- 346,467,307
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 346,467,307 | Nov 3, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 3, 2026 | 346,467,307 |